| Jessica P. Hwang, MD, MPH |
Present Title & Affiliation
N/A
Education & Training
Degree-Granting Education | |
| 1996 | The University of Texas Medical School, Houston, TX, MD, Medicine |
| 1996 | Emory University, Rollins School of Public Health, Atlanta, GA, MPH, Epidemiology and International Health |
| 1991 | The University of Texas, Austin, TX, BA, French Studies |
Postgraduate Training | |
| 4/2010-9/2010 | Clinical Safety and Effectiveness (CS&E) Program, "Patient Scheduling and Appointment Cycle Time in the Ambulatory Treatment Center", The University of Texas MD Anderson Cancer Center, Houston, TX |
| 7/1996-12/2000 | Residency, The University of Texas Medical School, Houston, TX, Mark A. Farnie, MD |
| 6/1995-8/1995 | William and Flora Hewlett Internship, Carter Presidential Center, Atlanta, GA, William H. Foege, MD |
| 8/1989-7/1990 | Sweet Briar College Junior Year in France Program,, University of Paris, The Institute of Pierre and Marie Curie, Paris, France |
Board Certifications
| 1/2002 | Internal Medicine |
Experience/Service
Academic Appointments
Assistant Professor, Tenure track, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2005-8/2012
Assistant Professor, Non-tenure track, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/2001-8/2005
Other Appointments/Responsibilities
Member, Community Clinical Oncology Program Research Base Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012
Honors and Awards
| 2008-2011 | National Institutes of Health Loan Repayment Program in Health Disparities, Loan Repayment Program, NIH |
Professional Memberships
| American Association for the Study of Liver Diseases Member, 2008-present |
| American Association for the Study of Liver Diseases - Hepatitis B Special Interest Group Member, 2011-present |
| American Association for the Study of Liver Diseases - Hepatobilary Neoplasia Special Interest Group Member, 2011-present |
| American Medical Association Member, 1999-present |
| American Public Health Association Reviewer, 2002-present |
| American Society of Clinical Oncology Member, 2002-present |
| Digestive Diseases and Sciences Reviewer, 6/2012 |
| Harris County Medical Association Member, 1999-present |
| Multinational Association of Supportive Care in Cancer Member, 2008-present |
| Society of General Internal Medicine Member, 2002-present |
| Texas Medical Association Member, 1999-present |
Selected Publications
Peer-Reviewed Original Research Articles | |
| 1. | Hwang JP, Fisch MJ, Zhang H, Kallen M, Routbort M, Lal L, Vierling JM, Suarez-Almazor M. Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy. J Oncol Pract 8(4):e32-39, 7/2012. PMCID: PMC3396827. |
| 2. | Kallen MA, Terrell JA, Lewis-Patterson P, Hwang JP. Improving wait time for chemotherapy in an outpatient clinic at a comprehensive cancer center. J Oncol Pract 8(1):1-7, 1/2012. PMCID: PMC3266321. |
Abstracts | |
| 1. | Hwang J, Fisch M, Lok A, Zhang H, Vierling J, Suarez-Almazor M. Effect of national recommendations on hepatitis B virus screening in a large U.S. cancer center. 2012 ASCO's Quality Care Symposium, 11/2012. |
| 2. | Escalante C, Meyers C, Reuben J, Wang X, Qiao W, Manzullo E, Alvarez R, Morrow PK, Gonzalez-Angulo A, Wang X.S, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, Overman M, Cleeland C. Randomized, double blind, placebo-controlled crossover trial of a sustained release methylphenidate in cancer-related fatigue. General Poster Session: Patient and Survivor Care. 2012 ASCO Annual Meeting, 6/2012. |
| 3. | Hwang J, Fisch M, Lok A, Zhang H, Vierling J, Suarez-Almazor M. Trends in Hepatitis B Virus Screening in a Large US Cancer Center. DoIM 2012 Research Retreat, 5/2012. |
| 4. | Hwang JP, Fisch M, Zhang H, Kallen MA, Vierling J, Suarez-Almazor ME. Hepatitis B Screening and Positivity Prior to Chemotherapy. 2010 Multinational Association of Supportive Care in Cancer (MASCC) International Symposium, 6/2010. |
Grant & Contract Support
| Title: | Widespread vs. selective screening for hepatitis B infection prior to chemotherapy, (additional funding pending full appropriation to NIH/NCI) |
| Funding Source: | NIH/NCI-R21 |
| Role: | Principal Investigator |
| Duration: | 1/10/2013 - 12/31/2014 |
Last updated: 2/25/2013
- Global Navigation
- About Us
- Locations
- Calendar
- Careers
- Publications
- How You Can Help
- Contact Us
- Newsroom
- Site Index
- Patient and Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children's Cancer Hospital
- Services & Amenities
- Education and Research
- Departments, Programs and Labs
- PeopleFinder
- Research at MD Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Alert Information
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
- Legal and Policy
- Legal Statements
- Site Policies
- Reporting Fraud, Waste & Abuse
© 2010 The University of Texas M. D. Anderson Cancer Center

